Navigation Links
ETEX Corporation Announces Distribution Agreement With Stryker
Date:7/14/2010

CAMBRIDGE, Mass., July 14 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, announced today that it has entered into a non-exclusive distribution agreement with Stryker's Spine division to market and sell the privately labeled Bio MatrX Structure and Bio MatrX Generate bone graft substitute products. Both products utilize ETEX's proprietary nanocrystalline calcium phosphate technology, which is wholly owned, developed and exclusively manufactured by ETEX Corporation.

(Logo:  http://photos.prnewswire.com/prnh/20080424/NETH117LOGO  )

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080424/NETH117LOGO )

BIO MatrX Structure is a highly porous, synthetic bone graft substitute that sets hard upon implantation for a complete defect fill. The resulting osteoconductive scaffold provides interconnected porosity and high surface area to facilitate cell mediated remodeling and new bone growth.

BIO MatrX Generate is a combination of ETEX's osteoconductive nanocrystalline calcium phosphate and Demineralized Bone Matrix (DBM) which is tested for osteoinductive potential by lot, after sterilization, in an in vivo athymic nude rodent muscle pouch model. The viscous putty sets hard after closure providing an osteoconductive scaffold to facilitate new bone growth.

Both materials are FDA cleared to be hydrated with saline or blood; and are indicated as bone void fillers of the pelvis, extremities and the posterolateral spine.

Brian Ennis, President and CEO of ETEX Corporation, comments: "ETEX Corporation is highly selective and discriminating in securing strategic partners. Stryker's Spine division possesses the desired distribution and marketing capabilities to increase exposure for ETEX's existing products and emerging technologies. The dynamic expansion of our distribution network is a direct reflection of the increasing market interest in our rapidly expanding product portfolio. We are pleased that Stryker has selected ETEX as its partner to complement their product offerings in the orthobiologic market segment."

About ETEX Corporation

Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems. For more information, visit www.etexcorp.com.


'/>"/>
SOURCE ETEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
2. Pharmos Corporation Reports 2008 Second Quarter Results
3. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
4. Genaera Corporation Announces Second Quarter Financial Results
5. MannKind Corporation Reports Second Quarter Financial Results
6. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
7. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
10. Mymetics Corporation Important Shareholders Information Conference Call
11. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Beach, SC (PRWEB) , ... April 26, 2017 ... ... the mind, has teamed up with NASA to showcase the future of deep ... Space Launch System (SLS) rocket and Orion spacecraft and includes a guest appearance ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced ... added to its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme ... only able to offer NAT screening for blood donors under an Investigational New Drug ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... EMEA and North America this May on the following ... , Donald H. Taylor, Chairman of the Learning and Performance Institute will be ...
(Date:4/26/2017)... , April 26, 2017  Genisphere LLC, provider ... has signed a collaborative and sponsored research agreement ... Silvia Muro . The overall goal of the ... of various 3DNA designs and formulations after ... diseases of the vasculature as well as inflammatory ...
Breaking Biology Technology:
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
(Date:3/20/2017)... 2017 PMD Healthcare announces the release of ... Management System (WMS), a remote, real-time lung health monitoring ... Healthcare is a Medical Device, Digital Health, and Chronic ... creating innovative solutions that empower people to improve their ... PMD developed the first ever personal spirometer, Spiro PD, ...
Breaking Biology News(10 mins):